Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Pfaar

Showing results (41-50 of 308) with videos related to

Pageof 31
Sort By:
Allergy|December 17, 2024
Algorithms in Allergy: Assessment of Rhinitis Using Allergen Exposure ChambersMarek Jutel, Magdalena Zemelka-Wiacek, Yoshitaka Okamoto, et al.
The Journal of Allergy and Clinical Immunology|December 22, 2014
Environmental exposure chambers in allergen immunotherapy trials: Current status and clinical validation needsKaren Rösner-Friese, Susanne Kaul, Stefan Vieths, et al.
Current Opinion in Allergy and Clinical Immunology|April 14, 2012
Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trialsMoises A Calderon, Andrea Eichel, Melina Makatsori, et al.
Allergy|August 7, 2023
How does allergen immunotherapy-induced tolerance improve the airway epithelial barrier function: A mechanistical-driven hypothesisOliver Pfaar, Benedikt Fritzsching, Hendrik Wolf, et al.
International Archives of Allergy and Immunology|October 27, 2010
Sublingual allergen-specific immunotherapy adjuvanted with monophosphoryl lipid A: a phase I/IIa studyOliver Pfaar, Christine Barth, Christine Jaschke, et al.
Allergy|July 13, 2018
Provocative proposal for a revised nomenclature for allergy and other hypersensitivity diseasesJohannes Ring, Marek Jutel, Nikos Papadopoulos, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|January 14, 2016
Management of the polyallergic patient with allergy immunotherapy: a practice-based approachPascal Demoly, Giovanni Passalacqua, Oliver Pfaar, et al.
Clinical Therapeutics|October 16, 2012
Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trialOliver Pfaar, Hendrik Wolf, Ludger Klimek, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|August 2, 2016
Patient engagement and patient support programs in allergy immunotherapy: a call to action for improving long-term adherencePascal Demoly, Giovanni Passalacqua, Oliver Pfaar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 10, 2017
Sublingual Immunotherapy Dosing Regimens: What Is Ideal?Jay J Jin, James T Li, Ludger Klimek, et al.
Pageof 31

Showing results (41-50 of 308) with videos related to

Sort By:
Pageof 31
Allergy|December 17, 2024
Algorithms in Allergy: Assessment of Rhinitis Using Allergen Exposure ChambersMarek Jutel, Magdalena Zemelka-Wiacek, Yoshitaka Okamoto, et al.
The Journal of Allergy and Clinical Immunology|December 22, 2014
Environmental exposure chambers in allergen immunotherapy trials: Current status and clinical validation needsKaren Rösner-Friese, Susanne Kaul, Stefan Vieths, et al.
Current Opinion in Allergy and Clinical Immunology|April 14, 2012
Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trialsMoises A Calderon, Andrea Eichel, Melina Makatsori, et al.
Allergy|August 7, 2023
How does allergen immunotherapy-induced tolerance improve the airway epithelial barrier function: A mechanistical-driven hypothesisOliver Pfaar, Benedikt Fritzsching, Hendrik Wolf, et al.
International Archives of Allergy and Immunology|October 27, 2010
Sublingual allergen-specific immunotherapy adjuvanted with monophosphoryl lipid A: a phase I/IIa studyOliver Pfaar, Christine Barth, Christine Jaschke, et al.
Allergy|July 13, 2018
Provocative proposal for a revised nomenclature for allergy and other hypersensitivity diseasesJohannes Ring, Marek Jutel, Nikos Papadopoulos, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|January 14, 2016
Management of the polyallergic patient with allergy immunotherapy: a practice-based approachPascal Demoly, Giovanni Passalacqua, Oliver Pfaar, et al.
Clinical Therapeutics|October 16, 2012
Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trialOliver Pfaar, Hendrik Wolf, Ludger Klimek, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|August 2, 2016
Patient engagement and patient support programs in allergy immunotherapy: a call to action for improving long-term adherencePascal Demoly, Giovanni Passalacqua, Oliver Pfaar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 10, 2017
Sublingual Immunotherapy Dosing Regimens: What Is Ideal?Jay J Jin, James T Li, Ludger Klimek, et al.
Pageof 31